Rob Koremans, CEO of Italian pharmaceutical company Recordati, weighs in on the company's purchase of Sanofi's rare immune ...

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

W ith flu season in full swing, finding effective medications to help with pesky symptoms is key in figuring out how to ...

AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...

Global Inhalable Drugs market size is expected to reach US$ 56.68 Bn by 2030, from US$ 34.86 Bn in 2023, exhibiting a CAGR of 7.2% during the forecast period. Mr. Shah Coherent Market Insights Pvt.

The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor ...

Delve into Sanofi's "play to win" strategy as investments are ramping up after their consumer health division's divestment.

Pink cocaine is an unpredictable party drug mix often containing ketamine, MDMA, and other substances, but it rarely contains actual cocaine. Due to batch-to-batch variability, users can't predict ...

Copyright 2024 The Associated Press. All Rights Reserved. Former Philippine President Rodrigo Duterte gestures during a Senate investigation on the war on the drugs ...

(RTTNews) - Sanofi announced that Beyfortus (nirsevimab) will be broadly available for babies born in Ontario, Quebec, Nunavut, Northwest Territories, and the Yukon this fall. The administration ...